Form D — Cambrian BioPharma Inc
0000950172-26-000183 · filed Jul 15, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $129,751,064
- Total sold
- $123,751,064
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cambrian BioPharma Inc
- CIK
- 1797409
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 228 Park Avenue South
NEW YORK, NY 10003 - Phone
- (516) 962-3186
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James Peyer · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Juliette Han · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Mark Nuttall · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Ruth Thieroff-Ekerdt · Executive OfficerNew York, NY Find on LinkedIn ↗
-
William DeVaul · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Christian Angermeyer · DirectorBirkirkara, O1 Find on LinkedIn ↗
-
Maryanna Saenko · DirectorLos Altos, CA Find on LinkedIn ↗
-
Brenton L. Saunders · DirectorBridgewater, NJ Find on LinkedIn ↗
-
Paul Farr · DirectorSanta Monica, CA Find on LinkedIn ↗
-
Martin Gunhaga · DirectorUmea, V7 Find on LinkedIn ↗
-
Lorin Van Nuland · DirectorBirkirkara, O1 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗